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INTRODUCTION 
 
             Pharmaceutical analysis deals not only with medicaments (drugs and 
formulations), but also with their precursors i.e. with the raw material whose degree 
of purity, which in turn decides the quality of medicaments. The quality of a drug is 
determined, after establishing its authenticity, which is carried by testing its purity and 
the quality of the pure substance in the drug and its formulations. 
 
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC): 
            High-performance liquid chromatography is a chromatographic technique 
used to separate the components in a mixture, to identify each component, and to 
quantify each component .The method involves a liquid sample being passed over a 
solid adsorbent material packed into a column using a flow of liquid solvent. Each 
analyte in the sample interacts slightly differently with the adsorbent material, thus 
retarding the flow of the analytes. If the interaction is weak, and the analytes flow off 
the column in a short amount of time, and if the interaction is strong, then the elution 
time is long. 
           Chromatography may be defined as a method of separating a mixture of 
components into individual components through equilibrium distribution between two 
phases. (Sharma B.K.1994)  
        The HPLC method was considered the choice of estimation, since this method is 
the most powerful of all chromatographic and other separative methods. The HPLC 
method has enabled analytical chemist to attain great success in solving his analytical 
problems. The HPLC is the method of choice in the field of analytical chemistry, 
since this method is specific, robust, linear, precise, and accurate and the limit of 
detection is low and also it offers the following advantages. 
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The schematic representation of an HPLC instrument typically includes a 
sampler, pumps, and a detector. The sampler brings the sample mixture into the 
mobile phase stream which carries it into the column. The pumps deliver the desired 
flow and composition of the mobile phase through the column. The detector generates 
a signal proportional to the amount of sample component emerging from the column, 
hence  allowing for quantitative analysis of the sample components .A digital 
microprocessor and user software  control the HPLC instrument and provide data 
analysis. Some models of mechanical pumps in a HPLC instrument can mix multiple 
solvents together in ratios changing in time, generating a composition gradient in the 
mobile phase. Various detectors are in common use, such as UV/Vis, photodiode 
array (PDA) or Refractive index (RI). 
 
 
 
SCHEMATIC REPRESENTATION OF HPLC SYSTEM 
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CHROMATOGRAPHY AND ITS TYPES 
Chromatography is a family of analytical chemistry techniques for the 
separation of mixtures. It involves passing the sample, a mixture that contains the 
analyte, in the "mobile phase", often in a stream of solvent, through the "stationary 
phase." The stationary phase retards the passage of the components of the sample. 
When components pass through the system at different rates they become separated in 
time, like runners in a marathon. Ideally, each component has a characteristic time of 
passage through the system. This is called its "retention time."  
A physical separation method in which the components of a mixture are 
separated by differences in their distribution between two phases, one of which is 
stationary (stationary phase) while the other (mobile phase) moves through it in a 
definite direction. The substances must interact with the stationary phase to be 
retained and separated by it. 
A chromatograph takes a chemical mixture carried by liquid or gas and 
separates it into its component parts as a result of differential distributions of the 
solutes as they flow around or over a stationary liquid or solid phase. Various 
techniques for the separation of complex mixtures rely on the differential affinities of 
substances for a gas or liquid mobile medium and for a stationary adsorbing medium 
through which they pass; such as paper, gelatin, or magnesium silicate gel.  
Analytical chromatography is used to determine the identity and concentration 
of molecules in a mixture. Preparative chromatography is used to purify larger 
quantities of a molecular species.  
 
.  
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THE DIFFERENT TYPES OF CHROMATOGRAPHY 
 Adsorption Chromatography 
Adsorption chromatography is probably one of the oldest types of 
chromatography around. It utilizes a mobile liquid or gaseous phase that is adsorbed 
onto the surface of a stationary solid phase. The equilibration between the mobile and 
stationary phase accounts for the separation of different solutes. 
 Partition Chromatography  
This form of chromatography is based on a thin film formed on the surface of 
the solid support by a liquid stationary phase. Solute equilibrates between the mobile 
phase and the stationary liquid. 
 Ion Exchange Chromatography 
In this type of chromatography, the use of a resin (the stationary solid phase) 
is used to covalently attach anions or cations on it. Solute ions of the opposite charge 
in the mobile liquid phase are attracted to the resin by electrostatic forces. 
 Molecular Exclusion Chromatography 
Also known as gel permeation or gel filtration, this type of chromatography 
lacks an attractive interaction between the stationary phase and solute. The liquid or 
gaseous phase passes through a porous gel, which separates the molecules according 
to its size. The pores are normally small and exclude the larger solute molecules, but 
allow smaller molecules to enter the gel, causing them to flow through a larger 
volume. This causes the larger molecules to pass through the column at a faster rate 
than the smaller ones. 
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 Affinity Chromatography 
This is the most selective type of chromatography employed. It utilizes the 
specific interaction between one kind of solute molecule and a second molecule that is 
immobilized on a stationary phase. For example, the immobilized molecule may be an 
antibody to some specific protein. When this molecule passes solute containing a 
mixture of proteins, only the specific protein is reacted to this antibody, binding it to 
the stationary phase. 
This protein is later extracted by changing the ionic strength or pH. 
Fundamental attitude  
In all chromatography there is a mobile phase and a stationary phase. The 
stationary phase is the phase that doesn't move and the mobile phase is the phase that 
does move. The mobile phase moves through the stationary phase picking up the 
compounds to be tested. As the mobile phase continues to travel through the 
stationary phase it takes the compounds with it. At different points in the stationary 
phase the different components of the compound are going to be absorbed and are 
going to stop moving with the mobile phase. This is how the results of any 
chromatography are gotten, from the point at which the different components of the 
compound stop moving and separate from the other components.  
In paper and thin-layer chromatography the mobile phase is the solvent. The 
stationary phase in paper chromatography is the strip or piece of paper that is placed 
in the solvent. In thin-layer chromatography the stationary phase is the thin-layer cell. 
Both these kinds of chromatography use capillary action to move the solvent through 
the stationary phase. 
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TYPES OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
 Based on modes of chromatography  
 Normal phase chromatography 
 Reverse phase chromatography  
  Based on principles of separation  
 Adsorption chromatography 
 Ion exchange chromatography 
 Ion pair chromatography 
 Size exclusion chromatography  
 Affinity chromatography  
 Chiral phase chromatography  
  Based on elusion technique  
 Isocratic separation  
 Gradient separation  
  Based on the scale of operation  
 Analytical HPLC  
 Preparative HPLC 
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COMPONENTS OF HPLC SYSTEM: 
 
Pump 
 
Pump generates a flow of elute from the solvent reservoir to the system. Most 
pumps used in current LC system generate the flow by back-and forth motion of a 
motor –driven piston. (Reciprocating pumps). Because of this piston motion, it 
produces “pulses”. There have been large system improvements to reduce this 
pulsation and the recent pumps create much less pulse compared to the older ones. 
Recent analysis requires very high sensitivity to quantify a small amount of analytes, 
and thus even a minor change in the flow rate can influence the analysis. Therefore, 
the pumps required for the high sensitivity analysis needs to be highly precise.  
Injector 
            An injector is placed next to the pump. The simplest method is to use a 
syringe, and the sample is introduced to the flow of eluent. Since the precision of LC 
measurement is largely affected by the reproducibility of sample injection, the design 
of injector is an important factor. The most widely used injection method is based on 
sampling loops. The use of auto sampler (auto-injector) system is also widely used 
that allows repeated injections in a set scheduled-timing. 
Column 
           The separation is performed inside the column; therefore, it can be said that the 
column is the heart of an LC system. The packing material generally used is silica or 
polymer gels. The eluent used for LC varies from acidic to basic solvents. Most 
column housing is made of stainless steel, since stainless is tolerant towards a large 
variety of solvents. However, for the analysis of some analytes such as biomolecules 
and ionic compounds, contact with metals is not desired, thus polyether ether ketone 
(PEEK) column housing is used instead. 
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Detector 
Separation of analytes is performed inside the column, Whereas a detector is used 
to observe the obtained separation .The composition of the eluent is consistent when 
no analyte is present .While the presence of analyte changes the composition of the 
eluent. What detector does is to measure these differences. This difference is 
monitored as a form of electronic signal. 
On-line detectors 
 Refractive index  
 UV/Vis Fixed wave length  
 UV/Vis variable  wave length  
 UV/Vis Diode array 
  Fluorescence 
 Conductivity 
  Mass –Spectrometric (LC/MS) 
 Evaporative light scattering 
Off-line detector 
 FTIR spiral disk monitor requires sample transfer on the germanium disk and 
following scanning in FTIR instrument. 
Recorder 
The change in eluent detected by a detector is in the form of electronic signal, 
and thus it is still not visible to our eyes. Nowadays, computer based data processor 
(integrator) is more common .There are software that are specifically designed for LC 
system. It provides not only data acquisition, but features like peak-fitting, base line 
correction, automatic concentration calculation, molecular weight determination, etc. 
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Degasser 
The eluent used for LC analysis may contain gases such as oxygen that are 
non-visible to our eyes. When gas is present in the eluent, this is detected as a noise 
and causes unstable baseline. Generally used method includes sparging (bubbling of 
inert gas), use of aspirator, distillation system, and/or heating and stirring. However, 
the method is not convenient and also when the solvent is left for a certain time period 
(e.g., during the long analysis), gas will dissolve back gradually. Degasser uses 
special polymers membrane tubing to remove gases. The numerous very small pores 
on the surface of the polymer tube allow the air to go through while preventing any 
liquid to go though the pore. By placing this tubing under low pressure container, it 
created pressure differences inside and outside the tubing (higher inside the tubing). 
This difference let the dissolved gas to move through the pores and remove the gas. 
Compared to classical batch type degassing, the degasser can be used on-line; it is 
more convenient and efficient.  
Column heater 
The LC separation is often largely influenced by the column temperature. Also 
for some analysis, such as sugar and organic acid, better resolutions can be obtained at 
elevated temperature (50~80oC). It is also important to keep stable temperature to 
obtained repeatable results even it is analyzed at around room temperature. There are 
possibilities that small different of temperature causes different separation results. The 
columns are generally kept inside the column oven (column heater).  
(Willard et.al, 1988).  
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INTRODUCTION TO HPLC METHOD DEVELOPMENT 
Method development has following steps: 
Collect information on sample, define separation goals 
 
 
Need for special HPLC procedure, sample pretreatment, etc. 
 
Choose detector and detector settings 
 
Choose LC method, preliminary run, select best separation conditions 
 
Optimize separation conditions 
 
Check for problems 
 
 
 
 
 
 
 
 
  
Quantitative calibration 
Recover purified material Qualitative method 
Validate method for release to routine laboratory 
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A good method development strategy should require only as many 
experimental runs as are necessary to achieve the desired final result. Finally method 
development should be as simple as possible, and it should allow the use of 
sophisticated tools such as computer modeling.  
The important factors, which are to be taken into account to obtain reliable 
quantitative analysis, are: 
1. Careful sampling and sample preparation. 
2. Appropriate choice of the column. 
3. Choice of the operating conditions to obtain the adequate resolution of the 
mixture. 
4. Reliable performance of the recording and data handling systems. 
5. Suitable integration/peak height measurement technique. 
6. The mode of calculation best suited for the purpose. 
7. Validation of the development method. 
(Synder et.al 1983).  
Careful sampling and sample preparation 
Before beginning method development, it is need to review what is known 
about the sample in order to define the goals of separation. The sample related 
information that is important is summarized in below.  
 Number of compounds present  
Chemical structure 
Molecular weight of compounds 
pka Values of compounds 
UV spectra of compounds 
Concentration range of compounds in samples of interest 
Sample solubility 
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The chemical composition of the sample can provide valuable clues for the 
best choice of initial conditions for an HPLC separation. 
Separation Goals 
The goals of HPLC separation need to be specified clearly, which include: 
 The use of HPLC to isolate purified sample components for spectral 
identification or quantitative analysis. 
 It may be necessary to separate all degradants or impurities from a product for 
reliable content assay. 
 In quantitative analysis, the required levels of accuracy and precision should be 
known (a precision of + 1 to 2% is usually achievable). 
 Whether a signal HPLC procedure is sufficient for a raw material or one or 
more different procedure are desired for formulations. 
 When the number of samples for analysis at one time is greater than 10, a run 
time less than 20 minutes often will be important.      
Sample preparation  
Sample come in various forms: 
 Solution ready for injection. 
 Solutions that require dilution, buffering, addition of and internal standard 
or other volumetric manipulation. 
  Solids must be dissolved or extracted. 
 Samples that require pretreatment to remove interference and /or protect the 
column or equipment from damage. 
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             Most samples for HPLC analysis require weighing and /or volumetric dilution 
before injection. Best results are often obtained when the composition of the sample 
solvents is close to that of the mobile phase since this minimizes baseline upset and 
other problems. Some samples require a partial separation (pretreatment) prior to 
HPLC, because of need to remove interference, concentrate sample analyte or 
eliminate “column killers”.  
             The samples may be of two types, regular or special. The regular samples are 
typical mixtures of small molecules (<2000Da) that can be separated by normal 
starting conditions. Whereas special samples are better separated under customized 
conditions given below. 
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Choice of the column 
            The separation of the column in HPLC is somewhat similar to the selection of 
columns in G.C, in the sense that, in the adsorption and partition modes, the   
separation mechanism is based on inductive forces, dipole-dipole interactions and 
hydrogen bond formation. In case of ion-exchange chromatography, the separation is 
 Sample Requirements 
Inorganic ions 
 
Isomers 
 
 
Enantiomers 
 
 
 
Biological 
 
 
 
Macromolecules 
 
Detection is primary problem; use ion 
chromatography. 
Some isomers can be separated by reserved-phase 
HPLC and are then classified as regular samples; 
better separations of isomers are obtained using either 
( 1)normal – phase HPLC or(2) reversed –phase 
separations with cyclodextrin-silica columns. 
These compounds require “chiral” conditions for their 
separation. 
Several factors make samples of this kind “special”, 
molecular conformation, polar functionality, and a 
wide range of hydrophobicity. 
 
“Big” molecules require column packing with large 
pores (>>10-nm diameters); in addition, biological 
molecules require special conditions as noted above.  
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based on the differences in the charge, size of the ions generated by the sample 
molecules and the nature of ionisable group on the stationary phase. In case of size –
exclusion chromatography the selection of the column is based on the molecular 
weight and size of the sample components. Selection of columns based on the method 
is briefly summarized in below. 
 
Method /Description /Columns Preferred Method 
Reversed – Phase HPLC 
Uses water- organic mobile phase 
 Columns: C18 (ODS), C8, Phenyl, 
trimethylsilyl (TMS), and cyano. 
Iron –pair HPLC 
Uses water – organic mobile phase, a 
buffer to control pH, and an ion –pair 
reagent 
Columns:  C18 , C8, Cyano 
Normal-phase HPLC 
Uses mixtures of organic solvents as 
mobile phase. Columns:  cyano, diol, 
amino, silica 
 
 
First choice for most samples, especially 
neutral or non-ionized compounds that 
dissolve in water-organic mixtures 
 
 
 
 
Acceptable choice for ionic or ionisable 
compounds, especially bases or cations. 
 
Good second choice when reserved-phase 
or ion-pair HPLC is ineffective; first 
choice for lipophilic samples that do not 
dissolve well in water-organic mixtures; 
first choice for mixtures of isomers and 
for preparative HPLC 
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Operating conditions to obtain the adequate resolution of the mixture 
             Most of the drug come under the category of regular samples mean typical 
mixtures of small molecules (<2000Da) that can be separated using more or less 
standardized starting conditions. Regular samples can be further classified as neutral 
or ionic. Samples classified as ionic include acids, bases, amphoteric compounds and 
organic salts. If the sample is neutral, buffers or additives are generally not required in 
the mobile phase. 
         Acids or bases usually require the addition of a buffer to the mobile phase. For 
basic or cationic samples, less acidic reserve phase columns are recommended. Based 
on recommendations of the conditions, the first exploratory run is carried and then 
improved systematically. On the basis of the initial exploratory run isocratic or 
gradient elution can be selected as most suitable. If typical reverse-phase conditions 
provided inadequate sample retention, it suggests the use of either ion-pair or normal 
Phase HPLC. Alternatively, the sample may be strongly retained with 100% ACN as 
mobile phase suggesting the use of non-aqueous reverse phase chromatography or 
normal phase HPLC.   
Method Development  
        One approach is to use an isocratic mobile phase of some average organic 
solvent strength (50%). A better alternative is to use a very strong mobile phase first 
(80 -100%) then reduce % B as necessary. The initial separation with 100% B results 
in rapid elution of the entire sample, but few groups will separate. Decreasing the 
solvent strength shows the rapid separation of all components with a much longer run 
time, with a broadening of latter bands and reduced retention sensitivity. Goals that 
are to be achieved in method development are briefly summarized in below. 
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Goal Comment 
Resolution 
 
Separation time 
Quantization 
 
Pressure 
 
Peak height  
Solvent 
consumption  
Precise and rugged quantitative analysis requires that Rs be 
greater than 1.5. 
< 5 – 10 min is desirable for routine procedures. 
≤ 2% for assay; ≤5% for less-demanding analyses. 
≤15% for trace analyses. 
<150 bar is desirable, <200 bar is usually essential (new 
column assumed). 
Narrow peaks are desirable for large signal/noise rations. 
Minimum mobile – phase use per run is desirable. 
 
Separation or resolution is a primary requirement in quantitative HPLC .The 
resolution (Rs) value should be maximum (Rs > 1.5) favors maximum precision. 
Resolution usually degrades during the life of the column and can vary from day to 
day with minor fluctuations in separation conditions. Therefore, values of Rs =2 or 
greater should be the goal during method development for sample mixtures. Such 
resolution will favor both improved assay precision and grater method ruggedness.  
               Some HPLC assays do not require base line separation of the compounds of 
interest (qualitative analysis).In such case only enough separation of individual 
components is required to provide characteristic retention times for peak 
identification. 
   The time required for a separation (runtime = retention time for base band) 
should be as short as possible and the total time spent on method development is 
reasonable (runtimes 5 to 10 minutes are desirable). 
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             Condition for the final HPLC method should be selected so that the operating 
pressure with a new column does not exceed 170 bar (2500psi) and upper pressure 
limit below 2000 psi is desirable. There are two reasons for this pressure limit, despite 
the fact that most HPLC equipment can be operated at much higher pressures. First, 
during the life of a column, the backpressure may rise by a factor of as much as due to 
the gradual plugging of the column by particulate matter. Second,  at lower pressure 
(<170 bars) pumps, sample valves and especially auto samplers operate much better, 
seals last longer, columns tend to plug less and system reliability is significantly 
improved. For these reasons, a target pressure of less than 50% of the maximum 
capability of the pump is desirable, when dealing with more challenging samples or if 
the goals of separation are particularly stringent, a large number of method 
development runs may be required to achieve acceptable separation. 
(Skoog et.al, 2009)  
Repeatable separation  
As the experimental runs described above are being carried out, it is important 
to confirm that each chromatogram can be repeated. When we change conditions 
(mobile phase, column, and temperature) between method development experiments, 
enough time must elapse for the column to come into with the new mobile phase and 
temperature. Usually column equilibration is achieved after passage of 10 to 20 
volumes of the new mobile phase through the column. However; this should be 
confirmed by repeating the experiment under the same conditions. When constant 
retention times are observed in two such back – to- back repeat experiments (+ 0.5% 
or better), it can be assumed that the column is equilibrated and the experiments are 
repeatable.  
 
Chapter – 1                                                                                                  Introduction 
 
Dept. of Pharmaceutical Analysis         19      J.K.K. Nattraja College Of Pharmacy 
 
Optimization of HPLC method  
During the optimization stage, the initial sets of conditions that have evolved 
from the first stages of development are improved or maximized in terms of 
resolution and peak shape, plate  counts asymmetry, capacity factor, elution time, 
detection limits, limit of quantitation and overall ability to quantify the specific 
analyte of interest. Optimization of a method can follow either of two general 
approaches: 
 Manual 
 Computer driven 
The manual approach involves varying one experimental variable at a time, while 
holding all other constant and recording changes in response. The variables might 
include flow rate, mobile or stationary phase composition, temperature, detection 
wavelength and pH. This approach to system is slow, time consuming and potentially 
expensive. However, it may provide a much better understanding of the principles and 
theory involved and of interactions of the variables.  
         In the second approach, computer driven automated method development, 
efficiency is optimized while experimental input is minimized. This approach reduce 
the time, energy and cost of all instrumental method development. 
The various parameters that include to be optimized during method development are  
A. Selection of mode of separation. 
B. Selection of stationary phase. 
C. Selection of mobile phase. 
D. Selection of detector. 
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Selection of mode of separation  
In reverse phase mode, the mobile phase is comparatively more polar than the 
stationary phase. For the separation of polar or moderately polar compounds, the most 
preferred mode is reverse phase. The nature of the analyte is the primary factor in the 
selection of the mode of separation. A second factor is the nature of the matrix.  
Selection of stationary phase 
             Selection of the column is the first and the most important step in method 
development. The appropriate choice of separation column indicates three different 
approaches. 
 Selection of separation 
 The particle size and nature of the column packing 
 The physical parameters of the column i.e. the length and the diameter some 
of the important parameters considered while selecting chromatographic 
columns are 
 Length and diameter of the column 
 Packing material 
 Shape of the particles 
 Size of the  particles 
 % of carbon loading 
 Pore volume 
 Surface area  
 Reproducibility and reliability 
 End capping 
In this case, the column selected had a particle size of 5µm and an internal 
diameter of 4.6mm.The column is selected depending on the nature of the solute and 
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the information about the analyte. Reversed phase mode of chromatography facilities 
a wide range of columns like dimethyl silane (C2), butysilane (C4), octylsilane (C8),  
Octadecyslane (C18), base deactivated silane (C18), BDS phenyl, Cyanopropyl (CN), 
nitro, amino etc. silica based columns with different cross linking’s in the increasing 
order of polarity are as follows:  
 
<………………..Non-polar………….moderately polar…………..polar……..> 
                             C18 < C8 < C6 < Phenyl < Amino < Cyano < Silica 
 
           C18 was chosen for this study since it is most retentive one. The sample 
manipulation becomes easier with this type of column. Generally longer columns 
provide better separation due to higher the theoretical plate numbers. Columns with 
5µm particle size give the best compromise of efficiency. 
      Peak shape is equally important in method development. Columns that provide 
symmetrical peaks are always preferred while peaks with poor asymmetry can result 
in, 
 Inaccurate plate number and resolution measurement 
 Imprecise quantitation 
 Degraded and undetected minor bands in the peaks tail 
 Poor retention reproducibility 
                 A useful and practical measurement of peak shape is peak asymmetry 
factor and peak tailing factor. Peak asymmetry is measured at 10% of full peak height 
and peak tailing factor at 5%. Reproducibility of retention times and capacity factor is 
important for developing a rugged and repeatable method.  
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           A column which gives separation of all the impurities and degradants from 
each other and from analyte peak and which is rugged for variation in mobile phase 
shall be selected. 
Selection of mobile phase 
          The primary objective in selection and optimization of mobile phase is to 
achieve optimum separation of all the individual impurities and degradants from each 
other and from analyte peak. 
          In liquid chromatography, the solute retention is governed by the solute 
distribution factor, which reflects the different interactions of the solute – stationary 
phase, solute-mobile phase, and mobile phase-stationary phase. For a given stationary 
phase, the nature and the composition of which has to be judiciously selected in order 
to get appropriate and required solute retention. The mobile phase has to be adapted in 
terms of elution strength (solute retention) and solvent selectivity (solute 
separation).Solvent polarity is the key word in the chromatographic separations since 
a polar mobile phase will give rise to low solute retention in normal phase and high 
solute retention in reverse phase LC. The selectivity will be particularly altered if the 
buffer pH is close to the pKa of the analytes. The following are the parameters, which 
shall be taken into consideration while selecting and optimizing the mobile phase. 
 Buffer 
 pH of the buffer 
 Mobile phase composition 
Buffers if any and its strength  
             Buffer and its strength play an important role in deciding the peak symmetries 
and separations. Some of the most commonly employed buffers are 
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 Phosphate buffers prepared using salts like KH2PO4, K2HPO4, NaH2PO4, and 
Na2HPO4. 
 Phosphoric acid buffers prepared using H3PO4. 
 Acetate buffers-ammonium acetate, sodium acetate etc. 
 Acetic acid buffers prepared using CH2COOH. 
            The retention also depends on the molar strengths of the buffer-molar strength 
is increasingly proportional to retention times. The strength of the buffer can be 
increasing, if necessary to achieve the required separations. The solvent strength is a 
measure of its ability to pull analyte from the column. It is generally controlled by the 
concentration of the solvent with the highest strength. The useful pH range for 
columns is 2 to 8, since siloxane linkages are cleaved below pH-2 while at pH values 
above eight, silica may dissolve. 
Mobile phase composition  
             Most chromatographic separations can be achieved by choosing the optimum 
mobile phase composition. This is due to the fact that fairly large amount of 
selectively can be achieved by choosing the qualitative and quantitative composition 
of aqueous and organic portions. Most widely used solvents in reverse phase 
chromatography are methanol and Acetonitrile. Experiments should be conducted 
with mobile phases having buffers with different pH and different organic phases to 
check for the best separations of analyte peak. A mobile phase which gives separation 
of analyte peak  
and which is rugged for variation of both aqueous and organic phase by at least + 
0.2% of the selected mobile phase composition should be used.  
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Selection of Detector 
            The detector was chosen depending upon some characteristic property of the 
analyte like UV absorbance, florescence, conductance, oxidation, reduction etc. The 
characteristics that are to be fulfilled by a detector to be used in HPLC determination 
are, 
 High sensitivity facilitating trace analysis 
 Negligible baseline noise to facilitate lower detection. 
 Large linear dynamic range. 
 Low dead volume. 
 Inexpensive to purchase and operate. 
            Pharmaceutical ingredients do not absorb all UV light equally, so that 
selection of detection wavelength is important. An understanding of the UV light 
absorptive properties of the organic impurities and the active pharmaceutical 
ingredient is very helpful. For the greatest sensitivity ƛmax should be used. Ultra 
violet wavelengths below 200nm should be avoided because detector noise increases 
in this region. Higher wave lengths give greater selectivity.  
Performance calculations 
             Carrying out system suitability experiment does the performance calculations. 
System suitability experiments can be defined as tests to ensure that the method can 
generate results of acceptable accuracy and precision. The requirements for system 
suitability are usually developed after method development and validations have been 
completed. The criteria selected will be based on the actual performance of the 
method as determined during its validation. For example, if sample retention times 
form part of the system suitability criteria, their variation SD can be determined 
during validation. 
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        System suitability might then require that retention times fall within a + 3 SD 
range during routine performance of the method. 
        The USP (2000) defines parameters that can be used to determine system 
suitability prior to analysis include plate number(n),tailing factor(T),resolution(Rs) 
and relative standard deviation (RSD) of peak height or peak area for respective 
injections. 
        The RSD of peak height or area of five injections of a standard solution is 
normally accepted as one of the standard criteria .For assay method of a major 
component, the RSD should typically be less than 1% for these five respective 
injections.  
    The plate number and / or tailing factor are used if the run contains only one peak. 
For chromatographic separations with more than one peak, such as an internal 
standard assay or an impurity method expected to contain many peaks, some measure 
of separations such as Rs is recommended. Reproducibility of tR  or k value for a 
specific compound also defines system performance. 
         The column performance can be defined in terms of column plate number. As 
the plate count is more the column is more efficient. (Lyoyd.R et.al 1997) 
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METHOD VALIDATION  
         The word “Validation’’ means “Assessment’’ of validity or action of proving 
effectiveness. 
Definition 
ICH defines validation as “establish the documented evidence which provides a high 
degree of assurance that a specific process will consistently produce a product of 
predetermined specifications and quantity attributes.’’ 
              Method validation is the process to confirm that the analytical procedure 
employed for a specific test is suitable for its intended use. Method need to be 
validated or revalidated. 
 Before their introduction into routine use 
 Whenever the conditions change for which the method has been validated, 
e.g., instrument with different characteristics 
 Whenever the method is changed, and the change is outside the original scope 
of the method. 
 Purpose of validation 
 Enable the scientists to communication scientifically and effectively on 
technical matter. 
 Setting the standards of evaluation procedures for checking compliance and 
taking remedial action. 
 Economic: Reduction in cost associated with process sampling and testing. 
 As quality of the product cannot always be assured by routine quality control 
because of testing of statistically insignificant number of samples. 
 Retrospective validation is useful for trend comparison of results compliance 
to CGMP/CGLP. 
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 Closure interaction with pharmacopoeial forum to address analytical 
problems. 
 International pharmacopoeial harmonization particularly in respect of 
impurities determination and their limits. 
           Method validation is completed to ensure that an analytical methodology is 
accurate, specific, reproducible and rugged over the specified range that an analyte 
will be analyzed. Method validation provides an assurance of reliability during normal 
use, and is sometime referred to as “the process of providing documented evidence 
that the method does what it is intended to do’’. 
For method validation, these specifications are listed in USP chapter <1225>,and can 
be referred to as the “eight steps of method validation”. as shown in figure below. 
These terms are referred to as “analytical performance parameters’’. or sometimes as 
“analytical figures of merit.’’  
In response to this situation, one of the first harmonization projects taken up by the 
ICH was the development of a guideline on the “Validation of Analytical Methods” 
Definitions and Terminology. “ICH divided the “Validation characteristics” 
somewhat differently, as outlined in Figure below 
 
 
 
 
 
 
 
The USP Eight steps of method validation 
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ICH Method Validation Parameters 
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Method validation parameters 
           The developed methods were validated by following steps: 
A. Accuracy 
         It is defined as closeness of agreement between the actual (true) value and mean 
analytical value obtained by applying a test method number of times. Spike and 
recovery studies are performed to measure accuracy; a known sample is added to the 
excipients and the actual drug value is compared to the value found by the assay. 
Accuracy is expressed as the bias or the % error between the observed value and the 
true value (assay value/actual value x 100 %.) 
          The accuracy is acceptable if the difference between the true value and mean 
measured value does not exceed the RSD values obtained for repeatability of the 
method. The parameter provides information about the recovery of the drug from 
sample and effect of matrix, as recoveries are likely to be excessive as well as 
deficient. 
Procedure: 
Use a minimum of 3 spiking concentrations in the excipients solution. Prepare 
two samples of each concentration. Test the 6 samples in triplicate on one run. 
Measure expected vs. average measured value. Calculate the% recovery. 
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B. Precision 
           The precision of an analytical method is the degree of agreement among 
individual test results when the method is applied repeatedly to multiple sampling of 
homogenous sample.  
            Precision is the measure of the degree of repeatability of an analytical method 
under normal operation and is normally expressed as the percent relative standard 
deviation (%RSD) or coefficient of variation (% CV) for a statistically significant 
number of samples. According to the ICH, precision should be performed at three 
different levels: repeatability, intermediate precision, and reproducibility.  
Repeatability is the result of the method operating over a short time interval under 
the same conditions (or) is the % RSD of multiple determinations of a single sample 
in a single test run (intra-assay precision). It should be determined from a minimum of 
nine determinations covering the specified range of the procedure (for example, three 
levels three repetitions each) or from a minimum of six determinations at 100% of the 
test or target concentration. 
Procedure: 
 Prepare three dilution of the sample (high/medium/low concentrations in the 
range).  
 Test 10 replicates of each dilution of the sample. 
 Calculate the average and standard deviation for each point on the curve. 
 Calculate the RSD for each point on the curve. 
Intermediate precision is the results from within lab variations due to random events 
such as different days, analysts, equipment, etc. In determining intermediate 
precision, experimental design should be employed so that the effects (if any) of the  
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  individual variables can be monitored (or) intermediate precision (also called inter-
assay precision) measure the % RSD for multiple determinations of a single sample, 
controls and reagents analyzed in several assay  runs in the same laboratory.  
Procedure: 
 Prepare three dilutions of the sample (high/medium/low concentrations in the 
range). 
 Test triplicates of each dilution of the sample inn three different assays. 
 Do for day- to –day variations 
 Do for lot-to- lot variations of assay materials 
 Do for technician – to – technician variation. 
 Calculate the average and standard deviation for each point on the curve for 
each individual test. 
 Calculate the RSD for each point on the curve between the assay runs. 
Reproducibility refers to the precision between laboratories usually in collaborative 
studies and not directly relevant to assay validation in a manufacturing facility. 
Documentation in support of precision studies should include the standard deviation, 
relative standard deviation, coefficient of variation, and the confidence interval. 
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C. Specificity 
              It is the ability of an analytical method to assess unequivocally the analyte of 
interest in the presence of components that may be expected to be present, such as 
impurities, degradation products and matrix components. It is not possible to 
demonstrate that an analytical procedure is specific for a particular analyte. In such 
case a combination of two or more analytical procedure is recommended to achieve 
the necessary level of discrimination. Lack of specificity of an individual analytical 
procedure may be compensated by other supporting analytical procedures or tests. 
               In case of the assay, demonstration of specificity requires that the procedure 
is unaffected by the presence of impurities or excipients. In practice, this can be done 
by spiking the drug substances or product with appropriate levels of impurities or 
excipients and demonstrating that the assay is unaffected by the presence of these 
extraneous materials. If the degradation product impurity standards are unavailable, 
specificity may be demonstrated by comparing the test results of samples containing 
impurities or degradation products to a second well-characterized procedure e.g., 
pharmacopoeia method or other validated analytical procedure (independent 
procedure). These comparisons should include samples stored under relevant stress 
conditions (e.g. light, heat humidity, acid/base hydrolysis, oxidation.ect.) 
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D. Limit of Detection 
             The limit of detection (LOD) is defined as the lowest concentration of an 
analyte in a sample that can be detected, not quantitated. It is a limit test that specifies 
whether or not an analyte is above or below a certain value. It is expressed as a 
concentration at a specified signal-to- noise ratio, usually two –or three-to-one. The 
ICH has recognized the signal-to-noise ratio convention, but also lists two other   
options to determine LOD: visual non-instrumental methods and a means of 
calculating the LOD. The method used to determine LOD should be documented and 
supported, and an appropriate number of samples should be analyzed at the limit to 
validate the level. 
Procedure 
 Prepare a standard concentration of the product in the appropriate solution. 
 Prepare a blank solution without any sample (zero concentration). 
 Perform the assay at least 3 times in duplicate according to SOP. 
 Measure the amount present in the sample and blank. 
 Calculate the average for the sample and blank. 
 Calculate and standard deviation of the blank. 
 Calculate the LOD as 3.3xSD/slope of linearity curve.           
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E. Limit of Quantitation 
              The limit of quantitation (LOQ) is defined as the lowest concentration of an 
analyte in a sample that can be determined with acceptable precision and accuracy 
under the stated operational conditions of the method. That is, as the LOQ 
concentration level decreases, the precision increases. If better precision is required, a 
higher concentration must be reported for LOQ. 
Procedure:  
             The calculation method is again based on the standard deviation of the 
response (SD) and the slope of the calibration curve (S)  according t the formula: 
LOQ = 10(SD/S). Again, the standard deviation of the response can be determined 
based on the standard deviation of the blank, on the residual standard deviation of the 
regression line, or the standard deviation of y- intercepts of regression lines.  
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F. Linearity: 
               It is ability of an assay to obtain test results, which are directly proportional 
to the concentration of an analyte in the sample. The determination of linearity will 
Identify the range of the analytical assay. It can be measured as slope of the regression 
line and its variance or as the coefficient of determination (R2) and correlation 
coefficient(R).  
Procedure: 
           Determining the coefficient of correlation R for dilutions of the sample over 
the range claimed for assay. 
1. Prepare 6 to 8 sample dilutions across the claimed range 
2. Test each dilution in triplicate for 3 runs 
3. Record expected values, actual values, and % recoveries for each run 
4. Analyze each set of dilutions as a linear curve and calculate R for each assay. 
Alternative: 
              Calculate the accuracy and precisions at each dilution. Range is the highest 
and lowest concentration with satisfactory accuracy and precision. If the validation 
study for an analytical test is well planed it should be possible to design the protocol 
to consider many of the parameters in a single series of test, for instance selectivity 
(specificity) linearity, range, accuracy and precision for a potency test.  
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 G. Range: 
            Range is the interval between the upper and the lower levels of analyte 
(inclusive) that have been demonstrated to be determined with precision, accuracy and 
linearity using the method as written. If the relationship between response and 
concentration is the linear, the range may be estimated by means of a calibration 
curve. 
           The range is normally expressed in the same units as the test results obtained 
by the method. The ICH guidelines specify a minimum of five concentration levels, 
along with certain minimum specified ranges. For assay the minimum specified range 
is from 80-120% of the target concentration. For an impurity test, the minimum range 
from the reporting level of each impurity, to 120% of the specification.  (For toxic or 
more potent impurities, the range should be commensurate with the controlled level).  
H. Ruggedness: 
               Ruggedness, according to the USP, is the degree of reproducibility of the 
results obtained under a variety of conditions, expressed as %RSD. The ruggedness of 
an analytical method is the degree of reproducibility of test results obtained by the 
analysis of the same samples under a variety of conditions such as different 
laboratories, different analysts, different instruments, different lot of reagents, 
different elapsed assay times, different assay temperatures different days, etc.  
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I. Robustness: 
               ICH defines robustness as a measure of the method’s capability to remain 
unaffected by small, but deliberate variations in method parameters. Robustness can 
be partly assured by good system suitability specifications. The evaluation of 
robustness should be considered during the development phase and depends on the 
type of procedure under study. It should show the reliability of an analysis with 
respect to deliberate variations in method parameters. If the results of a method or 
other measurements are susceptible to variations in method parameters, these 
parameters should be adequately controlled and a precautionary statement included in 
the method documentation. One consequence of the evaluation of robustness should 
be that a series of system suitability parameters (e.g., resolution test) is established to 
ensure that the validity of the analytical procedure is maintained whenever used. 
Examples of typical variation are: 
 Stability of analytical solutions 
 Extraction time 
In the case of liquid chromatography, examples of typical variations are  
 Influence of variations of pH in a mobile phase 
 Influence of variations in mobile phase composition 
 Different columns(different lots and/or suppliers) 
 Temperature 
 Flow rate. 
In the case of gas-chromatography, examples of typical variations are  
 Different columns(different lots and/or suppliers) 
 Temperature 
 Flow rate. 
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J. System Suitability Test  
            System suitability test  is commonly used to verity resolution, column 
efficiency and repeatability of the chromatographic system to ensure its adequacy for 
a particular analysis. According to the United States pharmacopoeia (USP) and the 
International Conference on Harmonization (ICH), SST is an integral part of many 
analytical procedure. 
            Primary SST parameters are most important as they indicate system 
specificity, precision and column stability. Other parameter include capacity factor 
(K) and signal to noise ratio(S/N) for impurity peaks. 
             The USP chromatography general chapter states “System suitability test are 
an integral part of gas and liquid chromatographic methods. They are used to verify 
that the resolution and reproducibility of the chromatographic system are adequate for 
the analysis to be done. The tests are based on the concept that the equipment, 
electronics, analytical operations and samples to be analyzed constitute an integral 
system can be evaluated as such.” (USP 36-NF 31, 621 – Chromatography)  
INTERPRETASTION OF CHROMATOGRAMS 
  
              Figure below represents a typical chromatographic separation of two 
substances, 1 and 2, where t1 and t2 are the respective retention times; and h, h/2, and 
Wh/2 are the height, the half – height, and the width at half-height, respectively, for 
peak1. W1 and W2 are the respective widths of peaks 1 and 2 at the base line. Air 
peaks are a feature of gas chromatograms and correspond to the solvent front in liquid 
chromatography. 
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Fig. 1 
 
 
 
                Chromatography retention times are characteristic of the compounds they 
represent but are not unique. Coincidence of retention times of a test and a reference 
substance can be used as a feature in construction of an identity profile but is 
insufficient on its own to establish identity. Absolute retention times of a given 
compound vary from one chromatogram to the next. 
Relative Retention times: 
 
 Relative retention time is calculated by the equation Rr = t2/t1  
t1 = Retention time of test. 
t2 = Retention time of reference substance, determined under identical experimental 
conditions on the same column.  
Relative Retention:  
  t2 – tM 
To calculate the relative retention (r) = --------- 
 t1-tM 
 
Where tM is the retention time of the non-retained marker.  
Resolution  
               The resolution R is a function of column efficiency, N and is specified to 
ensure that closely eluting compounds are resolved from each other, to establish the 
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general resolving power of the system, and to ensure that internal standards are 
resolved from the drug. 
 
 
Fig. 2 
R is determined by the equation: 
R=
૛(࢚૛ష࢚૚)
ࢃ૛శ ࢃ૚     Or 
        
                    2(t2-t2)       
R =    __________________ 
          1.70 (W1, h/2 + W2, h/2) 
 
t2 and t1 are the retention times of the components.  
 W2 and W1 are the corresponding width at the bases of the peaks obtained by 
extrapolating the relatively straight sides of the peaks to the base line. 
W1h/2 and W2h/2 are the corresponding peak width at half-height. 
Resolution  
               1.18(tR2 – tR1)      
R =  _______________ 
             (Wh1 + W h2) 
Where, t R2 > tR1 
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tR2 and tR1 = Retention times or distances along the baseline from the point of 
injection to the perpendiculars dropped from the maxima of two adjacent peak 
Wh1and Wh2 = peak width at half height.  
Theoretical Plates  
               Column efficiency also may be specified as system suitability requirements, 
especially if there is only one park of interest in the chromatograms. The number of 
the theoretical plates, N, is a measure of column efficiency. It is calculated by the 
equation. 
N= 16 [t/w] 2 or    N= 5.54 [t/w1/2]2 
t = Retention time of the substance. 
w = width of the peak at its base, obtained by extrapolating the relatively straight 
sides of the peak to the baseline.  
W1/2 = Peak width at half-height. 
 Precision: 
                Precision a measure of either degree of reproducibility or of repeatability  is 
determined by making replicate injections of standard preparation and calculating 
relative standard deviation. Unless otherwise specified in the individual monograph, 
data from five replicate injections of the standard preparation are used to calculate the 
relative standard deviations (SR), if the requirement is 2.0% or less; data from six 
replicate injections are used if the relative standard deviation requirement is more than 
2.0%. 
Relative Standard Deviation in percentage. 
SR (%) = ଵ଴଴
௑
[ට∑ (ଡ଼୧ି୶)ଶതതതതത
୒ିଵ
௜ୀ௡
௜ୀଵ ] 
x = Arithmetic mean of the set. 
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xi = An individual measurement in a set of N measurements. 
N= Number of individuals values 
Tailing Factor (or) Symmetry factor  
               Tailing factor, T, a measure of peak symmetry, is unity for perfectly 
symmetrical peaks and its value increases as tailing factor is pronounced (Fig 1). In 
some cases values less tan unity may be observed. As peak asymmetry increases, 
integration and hence precision becomes less reliable. 
 
 
Fig. 3 
 
Tailing factor, T = ௐ଴.଴ହ
ଶி
 
W0.05 = Width of peak at 5% height. 
F = Distance from the peak maximum to the leading edge of the peak, the distance is 
being measured at a point 5% of the peak height from baseline. 
Capacity Factor (Mass distribution ratio): 
          Capacity factor k’ of a sample component is a measure of the degree which that 
component is retained by the column relative to an unretained component  
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           Capacity factor is k, =
 ൫௧ೝష೟బ൯
௧బ
 
tr – is the elution time of retained component and 
t0 – is the elution time of the unretained sample. 
Signal to Noise Ratio:  
            S/N = ଶு
ு
 
Where, 
H  = Height of the peak corresponding to the component concerned, in the 
chromatogram obtained with the prescribed reference solution, measured from the 
maximum of the peak to the extrapolated baseline of the signal observed over a 
distance equal to 20 times the width at half-height.  
h = Range of the background noise in a chromatogram obtained after injection 
or application of a blank, observed over a distance equal to 20 times the width at half-
height of the peak in the chromatogram obtained with the prescribed reference 
solution and, if possible, situated equally around the place where this peak would be 
found.  
 
 
 
 
 
 
 
Fig. 4  
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Peak to Valley ratio 
          The peak-to-valley ratio (p/v) may be employed as a system suitability 
requirement in a test for related substances when baseline separation between 2 peaks 
is not reached  
     P/v = 
ு೛
ுೡ
 
Hp = Height above the extrapolated baseline of the minor peak, 
Hv = Height above the extrapolated baseline at the lowest point of the curve 
separating the minor and major peaks.(ICH 2007) 
 
 
 
 
 
 
Fig. 5 
 System Suitability Parameters and Recommendations: 
Parameter Recommendation 
Capacity Factor (k’) The peak should be well-resolved from the other peaks and 
the void volume, generally k’>2.0 
Repeatability RSD, ≤1% for N≥5 is desirable 
Relative retention  Not essential as long as the resolution is stated  
Resolution Rs of >2 between the peak of interest and the closed eluting 
Tailing Factor (T) T of ≤2 
Theoretical Plates (N) In general should be > 2000 
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STATISTICAL PARAMETERS 
Linear regression:  
         Once a linear relationship has been shown to have a high probability by the 
value of the correlation coefficient ‘r’, then the best straight line through the data 
points has to be estimated. This can often be done be done by visual inspection of the 
calibration graph, but in many cases it is far more sensible to evaluate the best straight 
line by linear regression (the method of least squares). 
The equation of straight line is y = mx + c 
Where, y the dependent variable is plotted as result of changing x, the independent 
variable.  
To obtain the regression line ‘y on x’ the slope ‘m’ of the line and the intercept ‘c’ on 
the y axis are given by the following equation. 
m= ۼ∑ܠܡି(∑ܠ)(∑ܡ)
ۼ∑ ܠ૛ି(∑ܠ)૛     and       c=   ۼ∑ܡ∑ ܠ૛ି(∑ܠ)(∑ܡ)ۼ∑ܠ૛ି(∑ܠ)૛  
Correlation coefficient: 
When the changes in one variable are associated or followed by changes in the order 
it is called correlation. To establish whether there is a liner relationship between two 
variables x1 and y1, use Pearson’s correlation coefficient r. 
r= ௡∑௫ଵ௬ଵି∑௫ଵ௬ଵ{[௡∑௫ଵଶି(∑௫ଵ)ଶ][௡∑௬ଵଶି(∑௬ଵ)ଶ]}ଵ ଶ⁄  
Where n is the number of data points. 
             The value of r must lie between +1 and -1, the nearer it is to +1, the greater 
the probability that a define linear relationship exists between the variables x and y, 
values close to +1 indicate positive correlation and values close to -1, indicate 
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negative correlation values of ‘r’ that tend towards zero indicate that x and y are not 
linearly related (they made be related in a non-linear fashion). 
Standard deviation: 
               The standard deviation measures the spread f the data about the mean value. 
It is commonly used in statics as a measure of precision statics as a measure of 
Precision and is more meaningful than is the average and is expressed mathematically 
as.  
S = ඩ෍ (Xi − x)ഥN − 1௜ୀ௡
௜ୀଵ
 
Where, 
S is the standard deviation. 
If N is large (50 or more) then of course it is immaterial whether the term in the  
Denomination is N-1 or N 
   Σ = sum 
X = observed values 
തܺ= Mean or arithmetic average = ΣX/N 
X - തܺ = deviation of a value from the mean  
N = Number of observations 
Percentage relative standard deviation 
    It is also known as coefficient of variation CV. It is defined as the standard 
deviation (S.D) expressed as the percentage of mean. 
  CV or % RSD = ௌ.஽
௑ത
 x 100 
Where, S.D = Standard deviation, 
               തܺ = Mean or arthimetic average. 
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The variance is defined as S2 and is more important in statistics than S itself. 
However, the latter is much more commonly used with chemical data.  
Standard Error of mean:  
        Standard error of mean can be defined as the value obtained by division of 
standard deviation by square root of number of observation. It is mathematically 
expressed as  
          S.E = ܵ.ܦ
√݊   
Where, n = number of observations. 
S.D = Standard Deviation(Riley et.al,2009)  
Data elements required for essay validation: 
It is not always necessary to evaluate every analytical performance parameter, as 
different test methods require different validation schemes. The most common 
categories of assays for which validation data should be required are as follows: 
i) Quantitation of major components or active ingredients. 
ii) Determination of impurities or degradation compounds. 
iii) Determination of performance characteristics 
Category – I: Analytical methods for quantitation of major components of bulk drug 
substances or active ingredients (including preservatives) in finished pharmaceutical 
products. 
Category – II: Analytical methods for determination of impurities in bulk drug 
substances or degradation compounds in finished pharmaceuticals products. These 
methods include quantitative essays and limits tests. 
Category – III: Analytical methods of determination of performance characteristics 
(E.g. dissolution, drug release).  
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The type of method and its intended use dictates which parameters are required to be 
investigated. They are illustrated in the below. 
 
Data elements required for assay validation 
 
Analytical 
Performance 
Parameter 
Assay 
Category-I 
Assay category Assay 
Category III Quantitative Limit Test 
Accuracy Yes Yes * * 
Precision Yes Yes No Yes 
Specificity Yes Yes Yes * 
LOD No No Yes * 
LOQ No Yes No * 
Linearity & 
range 
Yes Yes No * 
Ruggedness Yes Yes Yes * 
 
*may be required, depending on the nature of specific test.   
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 Comparison of Analytical Parameters Required for Assay validation 
         FDA reviewer 
Guidance 
USP General Chapter 
<1225> 
ICH Q2A Guidelines 
Accuracy Accuracy Accuracy 
Precision Repeatability 
Analysis 
Precision Precision 
Intermediate precision No Intermediate precision 
Reproducibility No No 
Specificity / selectivity Specificity Specificity 
Detection limit Detection limit Detection limit 
Quantitation limit  Quantitation limit Quantitation limit 
Linearity Linearity Linearity 
Range Range Range 
No Ruggedness No 
Robustness Robustness Robustness 
System suitability sample 
solution stability 
System suitability System suitability 
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LITERATURE REVIEW 
First Derivative Spectrophotometric Method for Simultaneous Estimation of 
Pantoprazole and Cinitapride in Combined Dosage Form. 
Patel.P.U. 2014 has reported a new, rapid, precise, accurate and sensitive first 
derivative spectrophotometric analytical method is proposed for the simultaneous 
estimation of Pantoprazole and Cinitapride in combined dosage form. The drugs 
obeyed the Beer’s law in the concentration range of 1-26 µg/mL. In the proposed 
method, absorbance was measured at 302 nm (Zero Crossing Point of Cinitapride) 
and 249 nm (Zero Crossing Point of Pantoprazole). Accuracy of the method was 
determined by recovery studies and was found to be 100.35 ± 0.18 and 99.61 ± 0.17 
for Pantoprazole and Cinitapride respectively. Therefore the proposed method can be 
used for routine analysis of both drugs in bulk as well as in pharmaceutical 
formulations 
Development and Validation of dual wavelength method for simultaneous 
estimation of Omeprazole and Cinitapride in combined capsule dosage form. 
Jagani.N.M 2012 has reported simple, sensitive, rapid, accurate and precise 
dual wavelength spectrophotometric method described for the simultaneous 
estimation of Omeprazole (OMP) and Cinitapride Hydrogen Tartrate (CNT) in 
combined dosage form. The method was based on determination of OMP at the 
absorbance difference between 275 nm and 255 nm and CNT at the absorbance 
difference between 288 nm and 312.9 nm. The linearity was obtained in the 
concentration range of 10-30 µg/mL and 1.5-4.5 µg/mL for OMP and CNT 
respectively. The proposed method was found to be simple and sensitive for the 
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routine quality control application of OMP and CNT in capsule dosage form. The 
results of analysis have been validated statistically and by recovery studies.  
Determination of Mosapride and Pantoprazole in a fixed-dose combination by 
UV Spectrophotometric methods and RP-HPLC 
Birajdar. A.S 2011 has reported An accurate and reproducible UV-
spectrophotometric methods and liquid chromatographic assay method were 
developed and validated for the determination of mosapride and Pantoprazole in 
capsule formulation. Two wavelengths were selected for each UV method, first 
simultaneous equation 274 nm, 288.2 nm and second Q value analysis method 274 
nm, 302 nm was the isobestic point for both the drugs. The 30 mM ammonium 
sulphate buffer: acetonitrile (50:50, v/v) was used for RP-HPLC to determine the 
contents of mosapride and Pantoprazole in combination-capsule dosage form. 
Linearity was evaluated over the concentration range of 5-50.0 µg/mL by UV and 0.5 
to 5.0 µg/mL by HPLC method respectively, for mosapride and Pantoprazole (the 
value of R2 0.999 found were by both the methods for mosapride and Pantoprazole).  
Simultaneous Spectrophotometric Estimation of Cinitapride Hydrogen 
Tartarate and Omeprazole in Capsule Dosage Form  
Satish.P 2013 has reported two simple, sensitive, rapid, accurate, precise and 
economical spectrophotometric methods were developed for the simultaneous 
estimation of Cinitapride hydrogen tartarate and omeprazole in two components solid 
dosage form. First method is based on the simultaneous equation and second method 
is based on Q-analysis (absorbance ratio method). Cinitapride hydrogen tartarate has 
absorbance maxima at 265 nm and omeprazole has absorbance maxima at 301 nm in 
methanol. The linearity was obtained in the concentration range of 1-20 µg/mL for 
both Cinitapride hydrogen tartarate and omeprazole. In the first method, the 
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concentrations of the drugs were determined by using simultaneous equations and in 
second method, the concentration of the drugs were determined by using ratio of 
absorbance at isoabsorptive point and at the λ-max of one of the drug. The results of 
analysis have been validated statistically and by recovery studies. 
Development and Validation of RP-HPLC method for simultaneous estimation 
of Naproxen and Pantoprazole in pharmaceutical dosage form. 
Kumar.R 2011 has reported a simple, sensitive, and precise high performance 
liquid chromatographic method for the analysis of naproxen and Pantoprazole has 
been developed, validated and used for the determination of compounds in 
commercial pharmaceutical products. The compounds were well separated on a 
Hypersil BDS C-18 reversed-phase column by use of a mobile phase consisting of 0.1 
M sodium acetate (pH 8.2), acetonitrile and methanol (70:20:10 v/v) at a flow rate of 
1.0 mL min-1 with detection wavelength at 285 nm. The linearity ranges were 5-70 
µg mL-1 for naproxen, and 5-40 µgmL-1 for Pantoprazole. The recovery amount was 
more than 99 %. The high recovery and low relative standard deviation confirms the 
suitability of the method for determination of naproxen and Pantoprazole in 
pharmaceutical dosage forms.  
Development and Validation of RP-HPLC for the Pantoprazole Sodium 
Sesquihydrate in Pharmaceutical dosage forms and Human Plasma. 
Prasanna Reddy B 2012 has reported A simple, sensitive and precise HPLC 
method for the analysis of Pantoprazole sodium and lansoprazole has been developed, 
validated and used for the determination of compounds in commercial pharmaceutical 
products. The compounds were well separated an isocratically on a C18 column [Use 
Inertsil C18, 5m , 150 mm x 4.6 mm] utilizing a mobile phase consisting of 
acetonitrile: phosphate buffer (60:40, v/v, pH 7.0) at a flow rate of 1.0 mL/min with 
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UV detection at 230 nm. The retention time of Pantoprazole sodium and lansoprazole 
was found to be 2.017 min and 2.538. The study showed that reversed-phase liquid 
chromatography is sensitive and selective for the determination of Pantoprazole 
sodium and lansoprazole using single mobile phase.  
Spectrophotometric methods for simultaneous estimation of pantoprazole and 
itopride hydrochloride in capsules 
Gupta K.R 2012 has reported, three simple, accurate and economical methods 
for simultaneous estimation of Pantoprazole and itopride hydrochloride in two 
component solid dosage forms have been developed. The proposed methods employ 
the application of simultaneous equation method, absorbance ratio method and 
multicomponent mode of analysis method. In distilled water Pantoprazole shows 
λmax at a wavelength of 289.0 nm while itopride hydrochloride shows λmax at a 
wavelength of 258.0 nm also the drugs show an isoabsorptive point at a wavelength of 
270.0 nm. For multicomponent method, sampling wavelengths 289.0 nm, 270.0 nm 
and 239.5 nm were selected. All these methods showed linearity in the range from 4-
20 µg/mL and 15-75 µg/mL for Pantoprazole and itopride hydrochloride respectively. 
The results of analysis have been validated statistically and by recovery studies.  
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CINITAPRIDE 
 
Structure   :                          
                                     
Molecular Formula :    C21H30N4O4 
IUPAC name             :     4-amino-N-[1-(cyclohex-3-en-1-ylmethyl) piperidin- 4 yl]-
2-ethoxy-5-nitrobenzamide  
Molecular weight      :    402.4873 
Description                 :   Yellow crystalline powder. 
Solubility                    :  Sparingly soluble in water & in glacial acetic acid (1 in 100). 
pKa                             :    16.32 
Category   :    Anti emetic. 
Pharamacokinetic data: 
 Absorption : The absorption of Cinitapride (12mg) following oral 
administration was rapid, with peak levels being achieved 2 h after dosing; 
absorption following intramuscular administration (4mg) was even more 
rapid, with peak levels (50% more that oral levels) being achieved 1 h after 
dosing.  
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 Metabolism : Metabolism is reported through cytochrome P450 CYP3A4 and 
CYP2C8 isozymes. Renal Excretion accounts for minor 
  Elimination :  The elimination profile was similar in oral and intramuscular 
administration. Renal route of elimination is minor. Urinary 24-h excretion of 
Cinitapride and its two major metabolites (principally the de-alkylated 
product) was no greater than 7% of the administered dose. 
 Half-life : 3-5 h during the first 8 h and a residual half-life greater than 15 h 
thereafter. 
Mechanism of action: 
Cinitapride is a substituted benzamide used for its prokinetic properties with 
5-HT receptor antagonist and agonist activity. (S.C Sweetman 2005) 
Toxicity:   
The symptoms of overdose include drowsiness, confusion and extra pyramidal 
effects. 
Uses: 
 For the treatment of gastrointestinal disorders associated with motility 
disturbances such as GERD, non-ulcer dyspepsia and delayed gastric 
emptying. 
Storage:   
Store between 15°C-25°C and protect from Moisture 
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PANTOPRAZOLE 
 
Structure                    :          
 
Molecular Formula    :     C16H15F2N3O4S  
IUPAC Name              :     6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl) 
methane] sulfinyl}-1H-1, 3-benzodiazole  
Molecular weight        :     383.37 
Description                  :     White to off-white powder  
Solubility                     :     Freely soluble in water, in methanol, and in dehydrated     
                                            Alcohol; practically insoluble in hexane and in  
                                            Dichloromethane. 
pKa :     15.76                                            
Category                      :     Proton pump inhibitor 
Mechanism of action   : 
Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in 
gastric acid production by forming a covalent bond to two sites of the (H+,K+ )- 
ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect 
is dose- related and leads to inhibition of both basal and stimulated gastric acid 
secretion irrespective of the stimulus. (C.F. Lacy 2005) 
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Pharamacokinetic data: 
Absorption: Pantoprazole is well absorbed. It undergoes little first-pass 
metabolism resulting in an absolute bioavailability of 
approximately 77%. 
Volume of  
Distribution: 11.0 to 23.6 L+ 
 
Protein binding: 98% primarily to albumin 
Metabolism: Pantoprazole is extensively metabolized in the liver through the 
cytochrome P450 (CYP) system. The main metabolic pathway 
is demethylation, by CYP2C19, with subsequent sulfation; 
other metabolic pathways include oxidation by CYP3A4. There 
is no evidence that any of the Pantoprazole metabolites have 
significant pharmacologic activity. 
Elimination: After administration of a single intravenous dose of 14C-
labeled Pantoprazole to healthy, normal metabolizer subjects, 
approximately 71% of the dose was excreted in the urine with 
18% excreted in the feces through biliary excretion 
Half-life: 1 hour 
 
Uses: 
Short-term (up to 16 weeks) treatment of erosive esophagitis 
Storage:   
 Store in well-closed light-resistant containers at 15-30 0C 
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s  
 
AIM AND PLAN OF WORK 
   The aim of the work is to develop a new method for the analysis of Cinitapride and 
Pantoprazole by RP–HPLC in capsule dosage form and to validate it as per ICH guidelines. 
The drugs analysis plays an important role in the development of drugs, their 
manufacture and therapeutic use. Pharmaceutical industries rely upon quantities chemical 
analysis to ensure that the raw material used and the final product obtained meets the required 
specification. The number of drugs and drug formulations introduced into the market has been 
increasing at an alarming rate. These drugs or formulations may be either new entities in the 
market or partial structural modification of the existing drugs or novel dosage forms or multi 
component dosage forms. 
  The multi component dosage forms proved to be effective due to combined mode of 
action on the body. The complicity of including the presence of multiple drug entities posses 
considerable challenge to the analytical chemist during the development of assay procedure. The 
estimation of individual drugs in these multi component dosage forms becomes difficult due to 
some extraction or isolation procedures. 
             For the present study Cinitapride and Pantoprazole was selected. The extensive literature 
survey carried out revealed that there is no method reported for the simultaneous estimation of 
these drugs, some methods for estimation of combined drugs by HPLC and spectrophotometer 
are available. Hence present study aim to developing a specific, precise, accuracy, linear, simple, 
rapid, and validated and cost effective RP-HPLC method for the simultaneous estimation of 
these drugs in combined dosage forms. 
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The core of project for RP-HPLC method was designed as follows: 
1. Selection of suitable wavelength, 
2. Selection of stationary phase and mobile phase, 
3. Selection of initial separation conditions, 
4. Optimization of chromatographic conditions, 
5. Estimation of Cinitapride and Pantoprazole  
6. Method validation. 
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MATERIALS AND METHODS 
  
MATERIALS USED FOR METHOD DEVELOPMENT AND VALIDATION 
 
INSTRUMENT USED: 
HPLC   :  Agilent 1260 series 
Software : Open lab 
pH Meter :  Range from 0  -14.Deep vision 
Analytical balance :  Accurate to 0.001g- Mettler 
Solvent filtration Unit :  Milli pore  
Syringe filters :  Nylon 0.22µ filter, PVDF 0.45 µ filters 
Centrifuge   :  Remi 
Sonicator :  1.5LH ultrasonic bath. 
APPARATUS USED: 
Graduated cylinder :  50mL, 100mL, and 1000mL – Borosil. 
Volumetric flask :  200mL, 100mL, 50mL –Borosil. 
Volumetric pipettes :  1mL, 10mL, 5mL, 4mL, 20mL –Borosil. 
Graduate pipettes : 5mL, 10mL, 1mL, 2mL –Borosil 
 
Specification 
Column C18 (Zorbax ODS Column 250mmX 4.6mm), 5µ 
Detector  DAD 
Temperature Ambient  
Wavelength 281 nm 
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Chemicals Used: 
 Methanol     : Merck HPLC grade 
 Acetonitrile                                         : Merck HPLC grade 
 Sodium hydroxide    : Merck AR grade 
 Water                                                  : Milli Q  
 Potassium dihydrogen phosphate : Merck AR grade 
 Ortho phosphoric acid  : Merck AR grade  
Standard Used                                                
 CinitaprideWorking Standard of Known potency 
 PantoprazoleWorking Standard of Known Potency  
Source of drugs: 
 Samples were collected from Avon organics 
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METHOD DEVELOPMENT 
Selection of Mobile Phase 
The pure drugs Cinitapride and Pantoprazole were injected in combination in 
the ratio of their contents in the capsule formulation to the chromatographic system, 
and run in different mobile phase compositions. Different mobile phases containing 
different compositions of methanol: water, acetonitrile: water, and acetonitrile: 
Phosphate buffer were tried for the selection of optimum conditions for the 
simultaneous determination of Cinitapride and Pantoprazole. It was found that 
optimal separation of the two components was achieved with acetonitrile and 
phosphate buffer (KH2PO4 buffer), compared to other mobile phases. Different ratios 
of the selected mobile phase were tried with varying flow rates and pH. Finally, the 
mobile phase composition selected for the chromatographic separation of Cinitapride 
and Pantoprazole was acetonitrile and phosphate buffer of pH 6.8 in the ration of 
50:50 v/v. 
Preparation of Mobile Phase 
Phosphate buffer pH 6.8: 50mL of 0.2M KH2PO4 and 22.4mL of 0.2M NaOH 
were dissolved in 100mL of distilled water. 
Mobile phase was prepared by mixing 500 mL of acetonitrile with 500 mL of 
phosphate buffer and its pH adjusted to 6.8. The mobile phase was sonicated for 15 
min and filtered through a 0.45 µm membrane filter paper. 
Preparation of Standard Stock Solutions 
25 mg each of standard Cinitapride and Pantoprazole were weighed accurately 
and transferred in to two separate 25mL flasks, and dissolved in 10mL of solvent, the 
volume was made up to the mark with solvent to obtain a solution of concentration of 
1000 µg/mL of each Cinitapride and Pantoprazole (standard stock solutions A1 and 
Chapter – 5                                                                                Materials and Methods 
 
Dept. of Pharmaceutical Analysis        63       J.K.K. Nattraja College Of Pharmacy 
 
A2 respectively). From the above stock solution A1 and A2 respectively 1.5mL and 
20 mL aliquots were pipetted in to a 50mL volumetric flask and dissolved in 25mL of 
the solvent and made up to the mark with the solvent to obtain a final concentration of 
400 and 30µg/mL of Pantoprazole and Cinitapride respectively (working stock 
solution). The stock solution were filtered through a 0.45µm membrane filter and 
sonicated for 15min in an ultrasonic bath sonicator. 
Preparation of Standard Solution: 
Transfer 5 mL of standard stock solution into a 20 mL volumetric flask, and dilute 
with diluent. 
Selection of Analytical Wavelength 
UV Spectrophotometric determination of Cinitapride and Pantoprazole of 
concentration 20µg/mL individually, in overlay mode shows that both the drugs 
absorb appreciably at 281nm, hence 281nm was selected as the detection wavelength 
(Fig.: 6). 
Selection of Analytical Concentration Range and Preparation of Calibration 
Curves for Cinitapride and Pantoprazole 
Appropriate aliquots of 0.5, 1, 1.5, 2, 2.5, 3 and 3.5mL were pipetted out from 
the standard stock solution in to a series of 10mL volumetric flasks. The volume was 
made up to the mark with the solvent resulting in the concentrations ranging from 1.5 
to 10.5 µg/mL Cinitapride and 20-140 µg/mL Pantoprazole. These seven level 
concentrations were prepared in triplicate and 20µl of these solutions were injected to 
chromatographic system. Peak areas respective to each concentration were recorded at 
281nm and a calibration graph of concentration vs. peak area was established. 
 Both the drugs follow the beer’s lamberts law in the concentration range of 
1.5-10.5 µg/mL Cinitapride and 20-140 µg/mL Pantoprazole. The regression analysis 
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was carried. The linearity of the peak response and adherence of the system to beers 
lamberts law was validated by high value of correlation coefficient and a % RSD of 
less than 2.0. 
Analysis of Capsule Formulation: 
Preparation of Sample Stock Solution: 
 The contents of twenty marketed Cintodac capsules were weighed accurately 
and their average weight was determined. A mass equivalent to 40 mg Pantoprazole 
and 3mg Cinitapride from the contents of the capsule were taken in a 100mL 
volumetric flask and dissolved in 50mL of the solvent. The solution was kept for 
sonication 15min. The solution was made up to the mark with the solvent and filtered 
through a 0.45 µ membrane filter paper sample stock solution ‘A’.  
Preparation of Sample Solution: 
Transfer 5.0 mL aliquot of the working sample stock solution A was diluted to 20 mL 
to obtain a concentration of 7.5 and 100µg/mL of Cinitapride and Pantoprazole 
respectively.  
 Six replicates solutions of this concentration were prepared. A 20µL volume 
of these solutions were injected to the chromatographic system and their respective 
chromatograms were recorded at 281nm. From the peak areas the amount of drug 
present in each sample was determined. 
 The objective of this experiment was to optimize the assay method for 
estimation of Cinitapride and Pantoprazole based on the literature survey and the trails 
made. The trials mentioned below describes how the optimization was done. 
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Trial-1: 
Mobile Phase  : Methanol and Water were mixed in the ratio  
   of50:50 and Sonicated to degas. 
Diluent : Mobile phase    
Chromatographic condition : 
Column : C18Zorbax ODS (250 x 4.6mm,5µ) 
Column Temperature      : Ambient 
Flow rate                         : 1.0ml/min  
Injection volume     : 20µl 
Detector wave length   : 281nm 
Run time      : 10 min 
Observation                 : Peaks are not eluted properly (Fig.: 7) 
Trial 2: 
Mobile Phase   : ACN and Water were mixed in the ratio  
   of50:50 and Sonicated to degas. 
Diluent  : Mobile phase    
Chromatographic condition    : 
Column : C18Zorbax ODS (250 x 4.6mm, 5µ) 
Column Temperature      : Ambient 
Flow rate                         : 1.0ml/min  
Injection volume     : 20µl 
Detector wave length   : 281nm 
Run time      : 10 min 
Observation: Merging of peaks was observed(Fig.: 8) 
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Trial 3: 
Mobile Phase   : Acetonitrile and Phosphate buffer (pH 6.8) were 
mixed in the ratio of 50:50 and Sonicated to 
degas. 
Diluent  : Mobile phase    
Chromatographic condition    : 
Column : C18Zorbax ODS (250 x 4.6mm, 5µ) 
Column Temperature      : Ambient 
Flow rate                         : 1.0ml/min  
Injection volume     : 20µl 
Detector wave length   : 281nm 
Run time      : 10 min 
Observation: Peaks were well resolved with good 
resolution,tailing and theoretical plate count. 
(Fig.: 9) 
OPTIMIZED HPLC METHOD 
After several trials with the different combinations and ratios of solvents, 
chromatographic parameters of trial-3 were optimized. 
 
Preparation of Mobile phase: 
Acetonitrile and Phosphate buffer (pH 6.8) were mixed in the ratio of 50:50 
and sonicated to degas. 
 
 
Chromatographic condition    : 
Column : Zorbax ODS (250 x 4.6mm, 5µ) 
Column Temperature      : Ambient 
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Flow rate                         : 1.0ml/min  
Injection volume     : 20µl 
Detector wave length   : 281nm 
Run time      : 10 min 
Conclusion:  
Good separation and resolution between Cinitapride and Pantoprazole peaks 
was observed. 
Procedure: 
Equilibrate  the column  with mobile phase  for  not less than  30 minutes  at  a flow  
rate of 1.0ml/min. Separately inject 20µl of diluents as  blank, standard solution (six 
times) and sample solution into the chromatographic system. Record the 
chromatograms and measure the peak responses. 
System suitability: The column efficiency as determined for the Cinitapride and 
Pantoprazole peak from standard solution is NLT 2000 theoretical plates. 
Tailing factor for Cinitapride and Pantoprazolepeak obtained from standard 
chromatogram should be NMT 2.0 The % RSD for the Cinitapride and Pantoprazole 
peaks for 6 replicate injections of standard  solution should be  NMT 2.0 
The retention time of Cinitapride peak is about 4.5 minutes and Pantoprazole peak is 
about 5.4 minutes  
Calculations: 
Quantity of Cinitapride and Pantoprazole present in the capsule as % of labeled 
amount: 
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For  CINITAPRIDE: 
 
 
        =                AT   x  WS  x  1.5   x  5x100 x20   x    P  x   AW  x  100 
                          -------------------------------------------------------------------------- 
                          AS  x   25  x  50  x  20 xWT   x 5x100  x    LC 
 
 
Where, 
AT: Area of Cinitapride peak in sample solution 
AS:  Average area of Cinitapride peak obtained from six replicate injectionsof  
standard solution. 
Ws:  Weight of Cinitapride working standard taken, in mg 
WT:  Weight of sample taken, in mg 
P:Purity of Cinitapride working standard used 
LC:Label claim of Cinitapride, in mg per capsule 
AW:  Average fill weight of capsule in mg. 
 
For  PANTOPRAZOLE: 
 
        =                AT   x  Ws  x   20   x 5 x100 x20x  P  x   AW  x  100 
                          ------------------------------------------------------------------------ 
                          AS  x   25  x    50  x  20 xWT   x 5x 100  x    LC 
 
 
Where, 
AT: Area of Pantoprazolepeak in sample solution 
As: Average area of Pantoprazole peak obtained from six replicate injectionsof 
standard solution. 
Ws:  Weight of Pantoprazoleworking standard taken, in mg 
WT:  Weight of sample taken, in mg 
P:  Purity of Pantoprazole working standard used 
LC :Label claimPantoprazole, in mg per capsule 
AW:  Average fill weight of capsule in mg. 
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METHOD VALIDATION 
Preparation of Standard Stock Solution: 
25 mg each of standard Cinitapride and Pantoprazole were weighed accurately 
and transferred in to two separate 25mL flasks, and dissolved in 10mL of solvent, the 
volume was made up to the mark with solvent to obtain a solution of concentration of 
1000 µg/mL of each Cinitapride and Pantoprazole (standard stock solutions A1 and 
A2 respectively). From the above stock solution A1 and A2 respectively 1.5mL and 
20 mL aliquots were pipetted in to a 50mL volumetric flasks and dissolved in 25mL 
of the solvent and made up to the mark with the solvent to obtain a final concentration 
of 400 and 30µg/mL of Pantoprazole and Cinitapride respectively (working stock 
solution). The stock solutions were filtered through a 0.45µm membrane filter and 
sonicated for 15min in an ultrasonic bath sonicator. 
Preparation of Standard Solution: 
Transfer 5mL aliquot of the working standardstock solution A was diluted to 
20 mL to obtain a concentration of 7.5 and 100µg/mL of Cinitapride and Pantoprazole 
respectively. 
Preparation of Sample Stock Solution: 
 The contents of twenty marketed Cintodac capsules were weighed accurately 
and their average weight was determined. A mass equivalent to 40 mg Pantoprazole 
and 3mg Cinitapride from the contents of the capsule were taken in a 100mL 
volumetric flask and dissolved in 50mL of the solvent. The solution was kept for 
sonication 15min. The solution was made up to the mark with the solvent and filtered 
through a 0.45 µ membrane filter paper sample stock solution ‘A’.  
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Preparation of Sample Solution: 
Transfer 5.0 mL aliquot of the working sample stock solution A was diluted to 
20 mL to obtain a concentration of 7.5 and 100µg/mL of Cinitapride and Pantoprazole 
respectively.  
SYSTEM SUITABILITY: 
The chromatographic system was equilibrated using the initial mobile phase 
composition, followed by 6 injections of the standard solution of concentration 7.5 
µg/mL Cinitapride and100 µg/mL Pantoprazole. The system suitability parameters 
including Theoretical plates, resolution, tailing factor and asymmetric factor were 
determined. The results were statistically analysed for the determination of standard 
deviation and %RSD. 
Table: 1 Data of system suitability chromatograms 
S.No 
Retention time Peak area 
CIN PAN CIN PAN 
1 4.547 5.397 7968111 92478206 
2 4.537 5.397 8085965 93227923 
3 4.540 5.400 7901974 92562832 
4 4.537 5.403 7938349 91486225 
5 4.530 5.407 7871160 91603127 
6 4.527 5.400 8062795 93050876 
Mean 4.535 5.400 7971392 92401532 
SD 0.005 0.006 86544.1 722731.5 
% RSD 0.12 0.12 1.09 0.78 
No. of Theoretical Plates 13127 14273 
Resolution 2.79 
Tailing factor 1.1 1.3 
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Table: 2 System suitability parameters 
 
 
 
 
 
 
 
 
Observation: 
From the system suitability studies it was observed that all the parameters are 
within limit, hence it is concluded that the Instrument, Reagents and Column are 
suitable to perform Assay. 
Acceptance criteria 
The % RSD of Cinitaprideand Pantoprazole peak areas should be NMT 2%. 
The number of theoretical plates (N) for the Cinitaprideand Pantoprazole peaks is NLT 
2000. 
The Tailing factor (T) for the Cinitaprideand Pantoprazole peaks is NMT 2.0. 
LINEARITY 
Aliquots of 0.5, 1, 1.5, 2, 2.5, 3, 3.5 mL of  working stock solution was serially 
diluted to 10mL in separate volumetric flasks to obtain a solution of concentrations in 
the range 1.5-10.5µg/mL of Cinitapride and 20-140µg/mL of Pantoprazole. 
 
 
Parameters CIN PAN 
Retention Time (min) 4.535 5.400 
Tailing 1.1 1.3 
Resolution - 2.79 
Theoretical Plates 13127 14273 
%RSD 1.09 0.78 
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The prepared solutions with increasing concentrations of Cinitapride and 
Pantoprazole reference standards were analysed chromatographically. For every 
concentration in µg/mL was measured the peak response value at 281nm. The 
experimental results were subjected to linear regression analysis.  
 The drugs Cinitapride and Pantoprazole follow the beer’s lamberts law in the 
concentration range of 1.5-10.5 µg/mL and 20-140 µg/mL respectively. Linearity 
determinations were carried in triplicate (n=3). Regression equation was established 
and the correlation coefficient was determined.  
Calibration Curve  
 
 
 
 
 
 
 
 
 
Fig.: 10 
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Table 3 HPLC Linearity Data of Cinitapride and Pantoprazole 
Cinitapride 
Concentration µg/mL Peak area n=1 Peak area n=2 Peak area n=3 
Level 1-1.5 1271341 1294718 1095714 
Level 2-3.0 2302253 2376086 2176603 
Level 3-4.5 3518631 3650508 3155130 
Level 4-6.0 4729404 4848928 4248871 
Level 5-7.5 5923659 5814888 5328019 
Level 6-9.0 7265947 7157380 6251377 
Level 7- 10.5 8155958 8168715 7368677 
Correlation coefficient  0.9995 0.9996 0.9999 
Slope 786823.2 777850.3 697674.94 
y- intercept 15077.17 80188.67 40255.41 
Pantoprazole  
Level 1-20 10005542 10703227 11703227 
Level 2-40 25379145 23830602 24832691 
Level 3-60 38938675 36537859 37765210 
Level 4-80 52442612 49024228 49417502 
Level 5-100 65873861 63834941 64910451 
Level 6-120 81936017 77674361 78676174 
Level 7-140 93249699 91640930 93641899 
Correlation coefficient 0.9993 0.9993 0.9992 
slope 682969.3 660024.74 668002.1 
y intercept -1829654.167 -2045963.41  -1641755.75 
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Table 4 Statistical Linearity Validation Data of Cinitapride and Pantoprazole 
Parameter Cinitapride Pantoprazole 
Linearity (µg/mL) 1.5-10.5 20-140 
Correlation coefficient 0.9997 0.9993 
Slope 754116.2 670332 
y intercept 45173.75 -1839124 
Limit of detection (µg/mL) 0.144 0.996 
Limit of quantitation (µg/mL) 0.431 2.987 
 
ACCURACY: 
Procedure for the Determination of Accuracy 
 Recovery studies were performed by applying standard addition method. To a 
known amount of the pre-analysed drug sample an 80%, 100%, and 120% of standard 
drug substance was added and suitably diluted.  The peak areas of the resultant 
solutions were measured at 281nm. The amount recovered at each recovery level was 
determined by substituting the peak response values in the regression equation. 
 In 80% recovery level concentration the amount of standard added was 2.4mg 
Cinitapride and 32mg Pantoprazole (80% addition). In 100% recovery level 
concentration the amount of standard added was 3mg Cinitapride and 40mg 
Pantoprazole (100% addition). In 120% recovery level concentration the amount of 
standard added is 3.6mg Cinitapride and 48mg Pantoprazole (120% addition). To 
each of the above three recovery levels a sample concentration equivalent to 0.6mg of 
Cinitapride and 8mg of Pantoprazole of the capsule dosage form was added.  
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 The contents corresponding to the three recovery levels were transferred in to 
three separate 100mL volumetric flasks and dissolved in a small quantity of methanol 
and sonicated in an ultrasonic bath sonicator for 10min. finally the volume was made 
up to the volume with methanol. This solution was filtered through Whatman filter 
paper No. 41. 
 The solution corresponding to the three recovery levels were prepared in 
triplicates. A 20µL volume of these solutions were injected to the chromatographic 
system and the respective chromatograms were recorded at 281nm. The %recovery at 
each level was calculated by substituting the peak area values in the regression 
equation and the results were statistically validated. 
Table 5 Data of Assay chromatograms 
S.No 
Retention time Peak area 
CIN PAN CIN PAN 
1 4.520 5.397 7925458 92781379 
2 4.526 5.391 8008349 93005443 
3 4.538 5.400 7891102 92620009 
4 4.540 5.408 8002877 91753925 
5 4.529 5.411 8024688 91980341 
6 4.533 5.397 7973557 92706273 
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Table 6Assay data of Cintodac Marketed Formulations 
 
S.No. 
Conc. present 
(µg/mL) 
Conc. obtained 
(µg/mL) 
% recovery (%w/w ) 
 CIN PAN CIN PAN CIN PAN 
1 7.5 100 7.472 99.77 99.63 99.77 
2 7.5 100 7.550 100.01 100.67 100.01 
3 7.5 100 7.440 99.60 99.20 99.60 
4 7.5 100 7.545 98.67 100.60 98.67 
5 7.5 100 7.565 98.91 100.87 98.91 
6 7.5 100 7.517 99.69 100.23 99.69 
Statistical validation data  
Drug Mean Standard deviation %RSD 
Cinitapride 7.515 0.05 0.66 
Pantoprazole 99.44 0.53 0.53 
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Table 7Accuracy Data of CIN and PAN 
Recovery 
level 
Amount of 
standard 
Amount of 
test added 
Total amount 
recovered 
% Recovery 
CIN PAN CIN PAN CIN PAN CIN PAN 
80% 
2.4 32 0.6 8 3.04 39.59 101.5 98.9 
2.4 32 0.6 8 2.99 39.41 99.8 98.5 
2.4 32 0.6 8 3.01 40.09 100.5 100.2 
100% 
3.0 40 0.6 8 3.61 48.21 100.5 100.4 
3.0 40 0.6 8 3.56 48.11 99.1 100.2 
3.0 40 0.6 8 3.64 48.68 101.1 101.4 
120% 
3.6 48 0.6 8 4.28 56.11 101.9 100.2 
3.6 48 0.6 8 4.20 56.76 100.2 101.4 
3.6 48 0.6 8 4.24 56.77 101.2 101.4 
 
Table 8 Statistical Validation Data of Accuracy 
Level of recovery 
Mean Standard deviation % RSD 
CIN PAN CIN PAN CIN PAN 
80 %  3.018 39.698 0.0258 0.3504 0.856 0.882 
100 % 3.608 48.339 0.0372 0.3070 1.032 0.635 
120% 4.245 56.551 0.0368 0.3787 0.867 0.669 
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PRESICION 
Procedure for the Determination of Precision: 
  The precision of the analytical method was determined a minimum of 6 
determinations at the 100% test concentrations. An amount equivalent to 3mg 
Cinitapride and 40mg of Pantoprazole was weighed accurately and transferred to a 
100mL volumetric flasks and dissolved in a small quantity of solvent and the content 
was kept in a sonicator for 10min. finally the volume was made up to the mark with 
the solvent. The solution was filtered through 0.45µ Nylon filter. The above sample 
solution was suitably diluted with the solvent to obtain a solution of concentration 
7.5µg/mL Cinitapride and 100µg/mL Pantoprazole. 
Intra-day Precision: 
  In intraday precision six replicate sample matrices containing 7.5µg/mL 
Cinitapride and 100µg/mL Pantoprazole were chromatographically analysed at 
different time intervals on the same day. The variation of the results within the same 
day was analysed and statistically validated. 
Table 9 Intraday Precision Areas of CIN and PAN 
S.No 
Retention time Peak area 
CIN PAN CIN PAN 
1 4.523 5.387 8002877 92081040 
2 4.529 5.411 7978349 92005111 
3 4.514 5.401 7991125 91127487 
4 4.522 5.384 8022087 91237418 
5 4.529 5.408 7924688 91304394 
6 4.505 5.391 7903049 93004714 
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Table 10 Intraday Precision Data of CIN and PAN 
S. 
No 
Conc. present 
(µg/mL) 
Result in mg/mL Result in % 
CIN PAN CIN PAN CIN PAN 
1 7.5 100 3.005 40.03 100.59 99.71 
2 7.5 100 2.996 39.99 99.77 100.32 
3 7.5 100 3.001 39.61 101.50 101.27 
4 7.5 100 3.012 39.66 101.15 100.97 
5 7.5 100 2.976 39.69 99.07 101.72 
6 7.5 100 2.968 40.43 100.28 100.16 
 
Table 11 Statistical Validation Data of Intraday Precision 
Drug component Mean Standard deviation %RSD 
Cinitapride 99.77 % 0.58 0.58 
Pantoprazole 99.76 % 0.78 0.78 
 
Inter-day Precision: 
  In inter-day precision six replicate sample matrices containing 7.5µg/mL 
Cinitapride and 100µg/mL Pantoprazole were chromatographically analysed on three 
consecutive (1st, 2nd and 3rd) days. The variation of the results within the same day 
was analysed and statistically validated. 
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Table: 12 Data of Interday precision chromatograms 
S.No 
Retention time Peak area 
CIN PAN CIN PAN 
1 4.520 5.397 7925458 92781379 
2 4.526 5.391 8008349 93005443 
3 4.538 5.400 7891102 92620009 
4 4.540 5.408 8002877 91753925 
5 4.529 5.411 8024688 91980341 
6 4.533 5.397 7973557 92706273 
 
Table 13 Inter day Precision Data CIN & PAN 
 
Sl. 
No 
Conc. present 
(µg/mL) 
Result in mg/mL Result in % 
CIN PAN CIN PAN CIN PAN 
1 7.5 100 2.989 39.91 99.63 99.77 
2 7.5 100 3.020 40.00 100.67 100.01 
3 7.5 100 2.976 39.84 99.20 99.60 
4 7.5 100 3.018 39.47 100.60 98.67 
5 7.5 100 3.026 39.56 100.87 98.91 
6 7.5 100 3.007 39.88 100.23 99.69 
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Table 14 Statistical Validation Data of Inter day Precision 
Drug component Mean Standard deviation %RSD 
Cinitapride 100.20 % 0.65 0.65 
Pantoprazole 99.44 % 0.53 0.53 
 
Acceptance criteria: 
The % RSD for the sample of Cinitapride and Pantoprazole should be NMT 
2.0%. 
LIMIT OF DETECTION: 
Limit of detection was determined based on the standard deviation of y 
intercepts of the regression line. The standard deviation of y intercepts obtained from 
the replicate measurements (n=3) was substituted for σ in the equation 3.3σ/S, and S 
is the mean of slope of the calibration curves. 
LIMIT OF QUANTITATION: 
 Limit of quantitation was determined based on the standard deviation of y- 
intercepts of the regression line. The standard deviation of y intercepts obtained from 
the replicate measurements (n=3) was substituted for σ in the equation 10σ/S, and s is 
the mean slopes of the three calibration curves. 
TheLODandLOQvalues weredetermined bythe formulae 
                  LOD=3.3XS/mandLOQ=10 S /m 
           Where,             Sisthe standard deviationoftheresponses 
mismeanoftheslopesof thecalibrationcurves. 
The results were given in the table. 
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SPECIFICITY: 
Specificity is defined as the degree to which the analyte measured is due only 
to the analyte of the interest and not to any other substances expected to be present in 
the sample matrix. For determining the specificity of the method the test solution was 
injected to the chromatographic system. Interferences due to the presence of 
excipients were not traced in the chromatogram and the chromatographic parameters 
were not affected. Thus the selected method is specific for the determination of the 
marketed formulation. 
ROBUSTNESS 
As part of evaluation of robustness, deliberate changes were made in the flow 
rate and Wavelength to evaluate the impact on the method. 
Effect of Variation of Flow Rate 
Standard solution prepared as per the test method was injected into the 
chromatographic system maintaining  flow rates, less flow (0.8ml/min) and more flow  
(1.2 ml/min). 
Table: 15 Robustness Data of CIN and PAN (0.8mL/min) 
S. No 
CIN PAN 
Rt (min) Peak area Rt (min) Peak area 
1 5.040 8592577 5.890 96167944 
2 5.057 8533424 5.893 97467968 
3 5.037 8516499 5.911 97162006 
4 5.041 8448044 5.880 95721698 
5 5.022 8575998 5.890 96478365 
6 5.048 8442165 5.896 96747880 
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mean 8518118 96624310 
SD 62945 641938 
%RSD 0.74 0.66 
 
Table: 16 Robustness Data of CIN and PAN (1.2mL/min) 
S. No 
CIN PAN 
Rt (min) Peak area Rt (min) Peak area 
1 4.220 7822305 5.090 89688853 
2 4.201 7738652 5.000 90397831 
3 4.198 7806791 5.054 90650360 
4 4.207 7744041 5.094 90106974 
5 4.205 7861332 5.039 91325064 
6 4.221 7876529 5.067 91038385 
mean 7808275 90534578 
SD 57700 601480 
%RSD 0.74 0.66 
 
 
Effect of Variation of Wavelength: 
Standard solution prepared as per the test method was injected into the 
chromatographic system maintaining flow rates, less wavelength 280nm, more 
wavelength 282nm and actual wavelength 281nm. (Fig.: 35-37). 
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Table: 17 Robustness Data of CIN and PAN 
S. No 
Peak areas 
280nm 282nm 
CIN PAN CIN PAN 
1 8002877 92620009 7938349 91486225 
2 8024688 91753925 7871160 91603127 
3 7973557 91980341 7968111 92478206 
4 7925458 92706273 8085965 93227923 
5 8008349 92781379 7901974 92562832 
6 7891102 93005443 7991125 91127487 
Mean 7971005 92474562 7959447 92080967 
SD 52455 492826 75668 799584 
%RSD 0.66 0.53 0.95 0.87 
 
 
Table 18 Statistical validation Data of Robustness 
Operational parameter Mean SD %RSD 
Cinitapride 
Flow rate +0.2mL/min 7808275 57700 0.74 
Flow rate -0.2mL/min 8518118 62945 0.74 
Wavelength +1nm 7959447 75668 0.95 
Wavelength -1nm 7971005 52455 0.66 
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Pantoprazole 
Flow rate +0.2mL/min 90534578 601480 0.66 
Flow rate -0.2mL/min 96624310 641938 0.66 
Wavelength +1nm 92080967 799584 0.87 
Wavelength -1nm 92474562 492826 0.53 
 
RUGGEDNESS 
The ruggedness of the developed analytical method was determined by analyst 
variation (analyst 1 and analyst 2). The results were analysed statistically and the 
effect of variations were estimated. 
  The ruggedness of the analytical method was determined by analysis of the 
solutions prepared by two analyst (analyst 1 and analyst 2). Appropriate aliquots of 
the working stock solution was transferred to a 20mL volumetric flasks and the 
volume was made up to the mark with the solvent to obtain a solution of 
concentration 7.5 µg/mL of Cinitapride and 100 µg/mL of Pantoprazole. Six 
replicates of this solution was prepared by analyst 1 and analyst 2.  A 20 µL of this 
solutions was analysed injected to the chromatographic system and the 
chromatograms were recorded. The results were statistically validated. 
 
 
 
 
 
 
 
Chapter – 5                                                                                Materials and Methods 
 
Dept. of Pharmaceutical Analysis        86       J.K.K. Nattraja College Of Pharmacy 
 
Table: 19 Ruggedness Data of CIN PAN 
S. No 
Peak areas 
Analyst-1 Analyst-2 
CIN PAN CIN PAN 
1 8115541 92181733 8083356 91986004 
2 8060085 93555226 7971160 92310031 
3 7984218 92862802 7992111 92676406 
4 7950042 91683225 8005965 93344454 
5 8039999 92009411 7951487 91964742 
6 7914530 92567000 7931125 92067487 
Mean 8010736 92476566 7989201 92391521 
SD 74724 671627 53433 538045 
%RSD 0.93 0.73 0.67 0.58 
 
 
Table 20 Statistical Validation Data of Ruggedness 
Variation Mean SD %RSD 
Cinitapride 
Analyst 1 8010736 74724 0.93 
Analyst 2 7989201 53433 0.67 
Pantoprazole 
Analyst 1 92476566 671627 0.73 
Analyst 2 92391521 538045 0.58 
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CHROMATOGRAMS 
UV Spectrum: 
 
Fig.: 6 
 
Method development trails in HPLC 
Trial-1 
 
 
Fig.: 7 
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Trial-2 
 
 
Fig.: 8 
 
Trial-3 (Optimized Chromatogram) 
 
Fig.: 9 
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Method Validation 
Blank 
 
Fig.10 
LINEARITY: 
Level-1 
  
Fig.:11 
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Level-2 
 
Fig.: 12 
 
Level-3 
 
Fig.: 13 
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Level-4 
 
Fig.: 14 
 
Level-5 
 
Fig.: 15 
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Level-6 
 
Fig.: 16 
 
Level-7 
 
Fig.: 17 
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ACCURACY 
Assay Chromatogram 
 
Fig.: 18 
 
Recovery Level-1 
 
Fig.: 19 
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Recovery level-2 
 
Fig.: 20 
 
Recovery level-3 
 
Fig.: 21 
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PRECISION: 
Intraday Precision: 
 
Fig.: 22 
 
Interday Precision 
 
Fig.: 23 
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RUGGEDNESS 
Analyst-1 
 
Fig.: 24 
 
Analyst-2 
 
Fig.: 25 
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ROBUSTNESS 
Wavelength at 280 nm: 
 
Fig.: 26 
 
wavelength at 282 nm: 
 
Fig.: 27 
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Flow rate at 0.8 mL/min: 
 
Fig.: 28 
 
Flow rate at 1.2 mL/min: 
 
Fig.: 29 
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RESULT AND DISCUSSION 
            A simple Reverse phase high performance liquid chromatographic method has been 
developed and subsequently validated for Cinitapride and Pantoprazole Capsules. 
 The separation was carried out by using a acetonitrile and phosphate buffer (pH) 6.8 
(50:50 v/v). The detection was carried out at 281 nm. The column was Zorbax ODS C18 (250 x 
4.6mm, 5µ). The flow rate was selected as 1mL/min.  
System suitability was assessed by injecting 6 replicate injections of 100% test 
concentration. Number of theoretical plates was more than 2000 for both the drugs and tailing 
factor was less than 1.5 for both Cinitapride and Pantoprazole was reported. A Resolution of 
greater than 2 was observed. The relative retention times of 6 replicate injections were shown in 
the table 1 and 2.  
The peak areas corresponding to the concentration range of Cinitapride 1.5 -10.5 µg/mL 
and Pantoprazole 20-140 µg/mL prepared in triplicate were plotted against the respective 
concentrations. The calibration curves were linear in the range studied for Cinitapride and 
Pantoprazole, respectively, with mean correlation coefficients (n = 3) of 0.999 and higher, the 
representative calibration curve was shown in fig. 10. The regression analysis was given in the 
tables 3 and 4. The chromatogram of linearity was given in figure 11-17. 
Accuracy of the method was examined by performing recovery studies by standard 
addition method for drug product. The recovery of the added standard to the drug product sample 
was calculated and it was found to be 100.64 %w/w and 100.29%w/w for Cinitapride and 
Pantoprazole respectively and the % RSD was less than 2 for both the drugs which indicates a 
good accuracy of the method. Chromatograms depicting the three recovery levels were given in 
figures 18-21. The results of recovery were given in the table 6-8. 
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The method was precise with a %RSD of less than 2 for both Cinitapride and 
Pantoprazole respectively. The results of intraday and inter day precision were given in the table 
9,10,12 and 13. The statistical validation data is given in the tables 11 and 14. Chromatograms of 
precision were given in the figure 22, 23. Limit of detection of Cinitapride and Pantoprazole 
were 0.34 µg/mL and 3.38µg/mL respectively. Limit of quanification of Cinitapride and 
Pantoprazole were 1.04 µg/mL and 10.15 µg/mL respectively. LOD and LOQ values were given 
in the table 4. 
Specificity of the chromatographic method was tested by injecting sample concentration 
prepared from marketed formulation. The response was compared with that obtained from the 
standard drug. The chromatogram confirms the presence of Cinitapride and Pantoprazole at 
4.5min and 5.4min respectively without any interference. Thus the developed method was 
specific to Cinitapride and Pantoprazole. An optimised chromatogram with the retention times of 
Cinitapride and pantoprazole was given in the figure 18. 
Ruggedness was carried out by change in the analyst (1 and 2), and instrument (Agilent). 
Solution of 100% concentration was prepared and injected in triplicate for each varied 
operational condition and % R.S.D was found to be less than 2. The Results were given in the 
table 19 & 20. The chromatograms were shown in the figure 24, 25. 
Robustness was carried out by change in the flow rate (± 0.2mL/min), and variation in 
wavelength (± 1 nm). Solution of 100% concentration was prepared and injected in six for each 
varied operational condition and % R.S.D was found to be less than 2. The Results were given in 
the table 16-18. The chromatograms were shown in the figure 26-29. 
Assay of marketed formulation; A 20 µL injection volume of test concentration 
containing 7.5 µg/mL Cinitapride and 100µg/mL Pantoprazole solution was injected in triplicate 
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to the chromatographic system and the peak response was measured. The content of each 
component in the formulation was estimated by comparing the peak area of the test sample with 
that of the peak area of the standard. The results of estimation were given in the table 5. The 
chromatogram was given in figure 18. 
Table -21 Analytical method validation report for Cinitapride and Pantoprazole 
 Parameter 
Results 
Cinitapride Pantoprazole 
wavelength (nm) 281 
Rt (min) 4.5 5.4 
Regression equation y=754116.2x+45173.75 y=670332x-1839124 
Correlation coefficient 0.9996 0.9992 
Accuracy 100.64 % 100.29 % 
LOD (µg/ml) 0.14 0.99 
LOQ (µg/ml) 0.43 2.98 
Assay 100.2 % 99.4 % 
Precision (%RSD) 
Intraday precision 0.58 0.78 
Inter day precision 0.65 0.53 
Robustness (%RSD) 
Flow rate 1.2mL/min 0.74 0.66 
Flow rate 0.8mL/min 0.74 0.66 
wavelength 280nm 0.66 0.53 
wavelength 282nm 0.95 0.87 
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Ruggedness (%RSD) 
Analyst 1 0.93 0.73 
Analyst 2 0.67 0.58 
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CONCLUSION 
A RP-HPLC method for Cinitapride and Pantoprazole were developed and 
validated in capsule dosage form as per ICH guidelines. The results are found to be 
complying with the acceptance criteria for each of the parameter. 
Agilent HPLC (Open Lab software with DAD detector) with Zorbax ODS C18 
(250X 4.6mm, 5µ) Packed Column, Injection  volume of 20µL was injected and eluted 
with  the Mobile phase ( Acetonitrile : Phosphate buffer pH 6.8, in the ratio of 
50:50%v/v) Which  was pumped at a flow rate of 1.0 mL at 281nm. The peak of 
Cinitapride and Pantoprazole was found well separated at 4.5 min, 5.4 min. The 
developed method was validated for various parameters as per ICH guidelines like 
system suitability, linearity, accuracy, precision, specificity, limit of detection, limit of 
quantitation, ruggedness, and robustness. 
Hence it is concluded that the assay method is found to be valid in terms of reliability, 
precision, accuracy and specificity and hence it is suitable for routine analysis as well as 
for stability analysis. 
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